Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Oncology Today with Dr Neil Love
00:00
When to Test for ESR1 Mutations
Rinath explains ESR1 is usually acquired after AI therapy and favors ctDNA testing after first-line metastatic endocrine therapy.
Play episode from 08:19
Transcript
